Full Press Release Details
Media
• November 13, 2024
IRWD Positive Sentiment
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Key Takeaway: Ironwood Pharmaceuticals announced its participation in the Jefferies London Healthcare Conference scheduled for November 2024. This event is significant for the company as it allows them to present their latest advancements and engage with investors. The conference is a key platform for networking and showcasing innovations in the healthcare sector.
Price reaction · baseline $4.395 (2024-11-12 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close · peak
-2%
Market Sentiment Analysis
POSITIVE FACTORS
- Ironwood Pharmaceuticals is actively participating in a notable healthcare conference.
- The event provides an opportunity for Ironwood to showcase its developments.
- Engagement in the Jefferies London Healthcare Conference reflects Ironwood's commitment to investor relations.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)
Frequently Asked Questions
When is the Jefferies London Healthcare Conference?
The Jefferies London Healthcare Conference is scheduled for November 2024.
What will Ironwood Pharmaceuticals do at the conference?
Ironwood Pharmaceuticals will participate and showcase its latest advancements.
Why is the conference important for Ironwood?
The conference is important for networking and engaging with investors.